We are live on ! Find out more
IMPV

Imperva, Inc.
IMPV

Delisted

IMPV was delisted on the 9th of January, 2019.

181 hedge funds and large institutions have $1.55B invested in Imperva, Inc. in 2017 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 84 increasing their positions, 48 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

217% more call options, than puts

Call options by funds: $28.6M | Put options by funds: $9M

75% more repeat investments, than reductions

Existing positions increased: 84 | Existing positions reduced: 48

17% more capital invested

Capital invested by funds: $1.32B → $1.55B (+$225M)

4% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 25

0% more funds holding in top 10

Funds holding in top 10: 44 (0)

1% less funds holding

Funds holding: 182181 (-1)

Holders
181
Holders Change
-1
Holders Change %
-0.55%
% of All Funds
4.51%
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.1%
New
26
Increased
84
Reduced
48
Closed
25
Calls
$28.6M
Puts
$9M
Net Calls
+$19.6M
Net Calls Change
+$9.2M
Name Holding Trade Value Shares
Change
Change in
Stake
T. Rowe Price Associates
101
T. Rowe Price Associates
Maryland
$761K +$653 +14 +0.1%
VOYA Investment Management
102
VOYA Investment Management
Georgia
$734K +$148K +3,167 +26%
FRM
103
Fox Run Management
Connecticut
$713K -$281K -6,032 -29%
Federated Hermes
104
Federated Hermes
Pennsylvania
$652K +$635K +13,614 +340,350%
Legal & General Group
105
Legal & General Group
United Kingdom
$649K +$135K +2,894 +27%
Wolverine Trading
106
Wolverine Trading
Illinois
$647K +$11.5K +246 +2%
CSS
107
Cubist Systematic Strategies
Connecticut
$621K +$156K +3,349 +35%
DTL
108
Dynamic Technology Lab
Singapore
$604K -$294K -6,309 -33%
SO
109
STRS Ohio
Ohio
$588K +$574K +12,300 New
Barclays
110
Barclays
United Kingdom
$581K +$376K +8,071 +198%
Mirae Asset Global Investments
111
Mirae Asset Global Investments
South Korea
$579K +$235K +5,041 +72%
UBS AM
112
UBS AM
Illinois
$572K -$90.3K -1,936 -14%
GCP
113
GSA Capital Partners
United Kingdom
$564K +$107K +2,287 +24%
PPA
114
Parametric Portfolio Associates
Washington
$556K +$27K +578 +5%
GC
115
Guggenheim Capital
Illinois
$554K -$38.7K -830 -7%
PG
116
PEAK6 Group
Illinois
$547K +$294K +6,311 +123%
ARTA
117
A.R.T. Advisors
New York
$514K -$1.96M -42,000 -80%
WMSA
118
Weiss Multi-Strategy Advisers
New York
$463K -$715K -15,328 -61%
Russell Investments Group
119
Russell Investments Group
United Kingdom
$440K +$396K +8,500 +1,235%
BLA
120
Balter Liquid Alternatives
Massachusetts
$418K +$408K +8,739 New
TMAM
121
Tokio Marine Asset Management
Japan
$412K
VanEck Associates
122
VanEck Associates
New York
$399K +$2.98K +64 +0.8%
LCM
123
Legato Capital Management
California
$368K +$359K +7,700 New
TI
124
Trexquant Investment
Connecticut
$359K +$74.9K +1,606 +27%
HCM
125
Highbridge Capital Management
New York
$358K +$560 +12 +0.2%

IMPV Hedge Fund Activity: Q2 2017 in Review

181 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Imperva, Inc. (IMPV) for Q2 2017, worth a combined $1.55B — up 17% from $1.32B a quarter earlier.

Buyers outnumbered sellers: 26 funds opened new IMPV positions and 25 closed out — a net gain of 1 holder — while 84 added to existing stakes and 48 trimmed.

The largest buyer was Citadel Advisors, adding an estimated $23.5M. The largest seller was Penserra Capital Management, exiting entirely with an estimated $36.7M sold.

  • 181 institutional investors held Imperva, Inc. (IMPV) as of Q2 2017, down from 182 in Q1 2017.
  • Funds reported $1.55B of Imperva, Inc. stock for Q2 2017, up 17% quarter-over-quarter.
  • 26 funds opened new Imperva, Inc. positions in Q2 2017 and 25 closed out, a net change of +1 holder.
  • The largest Imperva, Inc. buyer in Q2 2017 was Citadel Advisors, an estimated $23.5M added.
  • The largest Imperva, Inc. seller in Q2 2017 was Penserra Capital Management, an estimated $36.7M sold.

Based on aggregated 13F filings for Q2 2017.